Company Profiles

driven by the PitchBook Platform

Alpine Immune Sciences

Description

Developer of novel protein‐based immunotherapies created to offer next-generation immunotherapies to treat cancer and autoimmune disorders. The company's novel protein‐based immunotherapiesis designed to interact with multiple targets, including many present in the immune synapse, enabling patients avail novel protein-based discovery platform focused on inflammation and immuno-oncology.

2015

Founded

PUBLIC

Status

Reverse Merger

Latest Deal Type

$66.3M

Total Amount Raised

3

Investors

Description

Developer of novel protein‐based immunotherapies created to offer next-generation immunotherapies to treat cancer and autoimmune disorders. The company's novel protein‐based immunotherapiesis designed to interact with multiple targets, including many present in the immune synapse, enabling patients avail novel protein-based discovery platform focused on inflammation and immuno-oncology.

Website:

www.alpineimmunesciences.com

Ownership Status

Publicly Held

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals

Primary Office

201 Elliot Avenue West Suite 230 Seattle, WA 98119United States +1 (206) 788-4545
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Alpine Immune Sciences's full profile, request a free trial.

Alpine Immune Sciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Alpine Immune Sciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Alpine Immune Sciences Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alpine BioVenturesOtherMinority000 0000000 0000
Frazier Healthcare PartnersGrowth/ExpansionMinority000 0000000 0000
OrbiMedVenture CapitalMinority000 0000000 0000
Alpine BioVentures Other
Frazier Healthcare Partners Growth/Expansion
OrbiMed Venture Capital

Alpine Immune Sciences Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Jay Venkatesan MDPresident & Board Member
Paul RickeyChief Financial Officer
David MillerDirector & Secretary
Stanford Peng Ph.DExecutive Vice President of Research and Development and Chief Medical Officer
Michael Kornacker Ph.DCo-Founder, Senior Vice President Protein Engineering and Board Member
Jay Venkatesan MD President & Board Member
Paul Rickey Chief Financial Officer
David Miller Director & Secretary
Stanford Peng Ph.D Executive Vice President of Research and Development and Chief Medical Officer
Michael Kornacker Ph.D Co-Founder, Senior Vice President Protein Engineering and Board Member

Alpine Immune Sciences Board Members (4)

NameRepresentingRoleSinceContact
Info
James Topper Ph.DSelfBoard Member000 0000
Jay Venkatesan MDAlpine Immune SciencesPresident & Board Member000 0000
Mitchell Gold MDAlpine Immune SciencesCo-Founder, Executive Chairman and Chief Executive Officer000 0000
Peter Thompson MDOrbiMedPrivate Equity Partner000 0000
James Topper Ph.D Board Member Self
Jay Venkatesan MD President & Board Member Alpine Immune Sciences
Mitchell Gold MD Co-Founder, Executive Chairman and Chief Executive Officer Alpine Immune Sciences
Peter Thompson MD Private Equity Partner OrbiMed
Request full access to PitchBook